AzTrials
AzTrials

StrokeNCT06704997

Machine Learning to Predict Factors Affecting Rehabilitation Length of Stay and Healthcare Costs for Neurological Rehabilitation

An observational study of Stroke and Acquired Brain Injury, run by Tan Tock Seng Hospital at 1 site in Singapore.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The aim of this retrospective study is to ascertain total direct costs, rehabilitation length of stay (RLOS) and factors associated with RLOS for neurological inpatient rehabilitation at the tertiary care hospital. Read more about this study

Who is it for?
Ages 21 to 100 years
How many people
10,000 participants
Where
1 siteSingapore
Study dates
1 Jun 2024to 31 Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients who have admitted to the rehabilitation ward during their inpatient episode for neurological rehabilitation.

Who may be able to join

  • All patients who completed inpatient rehabilitation with the index conditions in their discharge summaries

Who cannot join

  • Did not complete inpatient rehabilitation as they are discharged against medical advice

Trial locations and contacts

1 site in 1 country.

Singapore1 site
  • Tan Tock Seng Hospital

    Singapore

Other trials in Singapore

About this study

Official title: Machine Learning Predictive Analysis of Key Factors Influencing Rehabilitation Length of Stay (RLOS) and Direct Hospitalization Costs for Neurological Inpatient Rehabilitation at Tertiary Care Hospital

The aim of this retrospective study is to ascertain total direct costs, rehabilitation length of stay (RLOS) and factors associated with RLOS for neurological inpatient rehabilitation at the tertiary care hospital.

Read the detailed description

The aim of the study is to identify factors that influence RLOS and the correlated costs for neurological rehabilitation in tertiary rehab using data extracted from EPIC. It is also aimed to identify the median direct costs to find out the main contributors to the costs in the local population. Lastly, the study aims to utilise artificial intelligence or machine learning to analyse the compiled data to develop a predictive model. The model aspires to understand factors associated with extended RLOS and to predict RLOS of patients who require neurological rehabilitation, aiding preemptive measures.

Keywords
Rehabilitation, Length of Stay, Stroke, Traumatic Brain Injury, Brain tumour, Cancer, Trauma, Acquired Brain Injury, Healthcare, Hospitalisation costs
Medical subject headings
Stroke, Brain Injuries, Brain Injuries, Traumatic, Brain Neoplasms, Central Nervous System Infections, Multiple Trauma, Neoplasms, Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06704997
Study groupRoleWhat they receive
Patients with tertiary neurological rehabilitationPatients with confirmed diagnosis of stroke, acquired brain injuries, traumatic brain injuries, brain tumours, central nervous system infections and polytrauma from acute neurological or neurosurgical units in Singapore. The cohort will be selected from the TTSH Rehabilitation Centre (TTSH RC) admissions from year 2016 to the present.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rehabilitation length of stay

    Duration of which patient is admitted to and discharge from the rehabilitation ward.

    Measured: 1998-2022

  2. Hospital bill

    Bill size of patient's stay in the rehabilitation ward, including subsidies, insurance and copayment.

    Measured: 2012-2022

  3. Housing type

    Type of housing to look at the socio-economics status of the patients.

    Measured: 2014-2023

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2024
  2. Study start1 Jun 2024
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
10,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06704997
Sponsor's protocol ID
DSRB 2023/00873
Status last verified
Oct 2026
First submitted
22 Nov 2024
Last updated
7 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: PI need to verify the quality of the data as extraction will involve accessing Ministry of Health government website to obtain deidentified data set

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Acquired Brain Injury, run by Tan Tock Seng Hospital at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rehabilitation length of stay (time frame: 1998-2022). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in